The overall objective of the project is to facilitate multi-center clinical nuclear medicine research by implementation and development of novel methodology and analyses in the diagnosis, follow up and treatment settings, to bring this field beyond state of the art for the betterment of patients across Norway. 

Hybrid PET/MRI will have a central role in this project, and therefor the focus is on patient groups where this modality has shown promising potential; In detection and characterization of cancer, as well as suspected dementia, for guiding treatment strategies in cancer, including implementation of multimodal data to guide latest technology within radiation, radionuclide and proton therapy and navigated neurosurgery, and to develop novel or improved, robust and clinically relevant image analysis tools. 

The multi-center data collection is coordinated from Trondheim, while patient inclusion and data collection are distributed across the partner sites in Tromsø, Trondheim, Bergen and Stavanger. In this project, hybrid imaging will merge nuclear medicine and radiological specialties to foster transdisciplinary collaborations at an expert level under international collaboration and supervision. The molecular and physiological data obtained with the unique combination of simultaneous PET/MRI will create the basis for new and improved understanding of disease pathophysiology, a steppingstone to develop new patient stratification and personalized treatment schemes.